ZALUTSKY MR[au] - Search Results

Year	Number of Results
1977	3
1984	2
1985	3
1986	4
1987	7
1988	9
1989	6
1990	10
1991	3
1992	7
1993	6
1994	14
1995	14
1996	17
1997	15
1998	13
1999	8
2000	9
2001	7
2002	5
2003	7
2004	14
2005	9
2006	15
2007	11
2008	6
2009	7
2010	7
2011	7
2012	7
2013	3
2014	7
2015	8
2016	9
2017	7
2018	8
2019	5
2020	6
2021	9
2022	3

1

Molecular imaging of hypoxia.

Chitneni SK, Palmer GM, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. Among authors: zalutsky mr. J Nucl Med. 2011 Feb;52(2):165-8. doi: 10.2967/jnumed.110.075663. Epub 2011 Jan 13. J Nucl Med. 2011. PMID: 21233176 Free PMC article. Review.

2

Astatine-211: production and availability.

Zalutsky MR, Pruszynski M. Zalutsky MR, et al. Curr Radiopharm. 2011 Jul;4(3):177-85. doi: 10.2174/1874471011104030177. Curr Radiopharm. 2011. PMID: 22201707 Free PMC article. Review.

3

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy.

Jannetti SA, Zeglis BM, Zalutsky MR, Reiner T. Jannetti SA, et al. Among authors: zalutsky mr. Front Pharmacol. 2020 Mar 3;11:170. doi: 10.3389/fphar.2020.00170. eCollection 2020. Front Pharmacol. 2020. PMID: 32194409 Free PMC article. Review.

4

Production, purification and availability of ²¹¹At: Near term steps towards global access.

Feng Y, Zalutsky MR. Feng Y, et al. Among authors: zalutsky mr. Nucl Med Biol. 2021 Sep-Oct;100-101:12-23. doi: 10.1016/j.nucmedbio.2021.05.007. Epub 2021 Jun 10. Nucl Med Biol. 2021. PMID: 34144505 Review.

5

Targeted radiotherapy of brain tumours.

Zalutsky MR. Zalutsky MR. Br J Cancer. 2004 Apr 19;90(8):1469-73. doi: 10.1038/sj.bjc.6601771. Br J Cancer. 2004. PMID: 15083170 Free PMC article. Review.

6

Radioimmunotherapy with alpha-particle emitting radionuclides.

Zalutsky MR, Pozzi OR. Zalutsky MR, et al. Q J Nucl Med Mol Imaging. 2004 Dec;48(4):289-96. Q J Nucl Med Mol Imaging. 2004. PMID: 15640792 Free article. Review.

7

Heterogeneity and vascular permeability of breast cancer brain metastases.

Babak MV, Zalutsky MR, Balyasnikova IV. Babak MV, et al. Among authors: zalutsky mr. Cancer Lett. 2020 Oct 1;489:174-181. doi: 10.1016/j.canlet.2020.06.012. Epub 2020 Jun 16. Cancer Lett. 2020. PMID: 32561415 Free PMC article.

8

Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.

Vaidyanathan G, Zalutsky MR. Vaidyanathan G, et al. Among authors: zalutsky mr. Curr Radiopharm. 2011 Oct;4(4):283-94. doi: 10.2174/1874471011104040283. Curr Radiopharm. 2011. PMID: 22202151 Free PMC article. Review.

9

Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates.

Zalutsky MR, Bigner DD. Zalutsky MR, et al. Acta Oncol. 1996;35(3):373-9. doi: 10.3109/02841869609101654. Acta Oncol. 1996. PMID: 8679269 Review.

10

Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies.

Zalutsky MR, Reardon DA, Pozzi OR, Vaidyanathan G, Bigner DD. Zalutsky MR, et al. Nucl Med Biol. 2007 Oct;34(7):779-85. doi: 10.1016/j.nucmedbio.2007.03.007. Epub 2007 May 11. Nucl Med Biol. 2007. PMID: 17921029 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results